首页 > 最新文献

European Archives of Oto-Rhino-Laryngology最新文献

英文 中文
Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps. 杜匹单抗:哮喘和特应性疾病患者对慢性鼻炎伴鼻息肉治疗的延迟反应。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-06-08 DOI: 10.1007/s00405-024-08738-2
Umberto Tanzini, Andrea Rampi, Alessandro Vinciguerra, Giulia Danè, Mona Rita Yacoub, Mario Bussi, Matteo Trimarchi

Purpose: Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a common disease, which was previously approached with sinus surgery or systemic corticosteroids. The advent of biological therapies radically changed the approach to this disease. On the other hand, there is scarce scientific evidence of how specific subsets of patients respond to this treatment.

Methods: this is a monocentric, prospective study investigating the long-term efficacy on biweekly 300 mg dupilumab therapy in CRSwNP, prescribed to 61 patients. Patients were evaluated at baseline and every 2 months for the first 6 months, then at 9, 12, 16, 20 and 24 months.

Results: dupilumab proved to be an effective treatment, neatly improving both subjective and objective measurements in CRSwNP. The main finding of the study is the difference between specific subgroups of patients: while the overall response is similar, patients with Th2 comorbidities such as asthma and atopy tend to reach a stable response later, with the improvement ongoing even after 6 months of therapy, while non-asthmatic, non-atopic patients attain an earlier stability in response.

Conclusions: dupilumab provides an excellent long-term control of CRSwNP, but the response in asthmatic and atopic patients appears to be different and delayed when compared to non asthmatic and non atopic ones.

目的:慢性鼻窦炎伴鼻息肉(CRSwNP)是一种常见疾病,以前多采用鼻窦手术或全身皮质类固醇治疗。生物疗法的出现从根本上改变了这种疾病的治疗方法。方法:这是一项单中心、前瞻性研究,调查了 61 名 CRSwNP 患者接受双周 300 毫克杜必鲁单抗治疗的长期疗效。患者在基线时接受评估,头 6 个月每 2 个月接受一次评估,然后在 9、12、16、20 和 24 个月时接受评估。该研究的主要发现是特定亚组患者之间的差异:虽然总体反应相似,但有 Th2 合并症(如哮喘和特应性)的患者往往较晚达到稳定反应,甚至在治疗 6 个月后仍有改善,而非哮喘、非特应性患者较早达到稳定反应。
{"title":"Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps.","authors":"Umberto Tanzini, Andrea Rampi, Alessandro Vinciguerra, Giulia Danè, Mona Rita Yacoub, Mario Bussi, Matteo Trimarchi","doi":"10.1007/s00405-024-08738-2","DOIUrl":"10.1007/s00405-024-08738-2","url":null,"abstract":"<p><strong>Purpose: </strong>Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a common disease, which was previously approached with sinus surgery or systemic corticosteroids. The advent of biological therapies radically changed the approach to this disease. On the other hand, there is scarce scientific evidence of how specific subsets of patients respond to this treatment.</p><p><strong>Methods: </strong>this is a monocentric, prospective study investigating the long-term efficacy on biweekly 300 mg dupilumab therapy in CRSwNP, prescribed to 61 patients. Patients were evaluated at baseline and every 2 months for the first 6 months, then at 9, 12, 16, 20 and 24 months.</p><p><strong>Results: </strong>dupilumab proved to be an effective treatment, neatly improving both subjective and objective measurements in CRSwNP. The main finding of the study is the difference between specific subgroups of patients: while the overall response is similar, patients with Th2 comorbidities such as asthma and atopy tend to reach a stable response later, with the improvement ongoing even after 6 months of therapy, while non-asthmatic, non-atopic patients attain an earlier stability in response.</p><p><strong>Conclusions: </strong>dupilumab provides an excellent long-term control of CRSwNP, but the response in asthmatic and atopic patients appears to be different and delayed when compared to non asthmatic and non atopic ones.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11416370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune checkpoint inhibitor combined with chemotherapy versus chemotherapy alone in the first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis of random controlled trials. 免疫检查点抑制剂联合化疗与单用化疗一线治疗复发性或转移性鼻咽癌:随机对照试验荟萃分析。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-06-24 DOI: 10.1007/s00405-024-08768-w
Shuangyue Wang, Xiaojie Huang, Rong Li, Ziyan Zhou, Min Kang

Purpose: Immune checkpoint inhibitor (ICI) monotherapy and chemotherapy (CT) have been used to treat recurrent or metastatic nasopharyngeal carcinoma (R/M-NPC), with demonstrated survival benefits and good safety. However, whether combination therapy is superior to CT alone remains unclear. We summarized the existing evidence comparing the effectiveness and toxicities of ICI combined with CT versus CT alone.

Methods: Online databases was conducted for eligible randomized controlled trials (RCTs) published up to November 1, 2023. Progression-free survival (PFS) and overall survival (OS) were the primary endpoint. Objective response rates (ORRs) and adverse events (AEs) were the secondary endpoint.

Results: Three randomized controlled trials (Capture-1st, JUPITER-02, and RATIONALE-309) were included. First-line ICI therapy combined with CT showed significant improvement in PFS (hazard ratio[HR], 0.53; 95% confidence interval[CI]: 0.44-0.64), OS (HR, 0.63;95%CI: 0.49-0.81) and ORRs (odds ratio[OR], 1.79;95%CI: 1.30-2.46), when compared with CT alone. AEs ≥ grade 3 during treatment and treatment-related deaths were not significantly different between the two groups.

Conclusions: In patients with R/M-NPC, ICI therapy combined with CT showed improved ORRs, PFS, and OS, with similar safety as CT alone.

目的:免疫检查点抑制剂(ICI)单药疗法和化疗(CT)已被用于治疗复发性或转移性鼻咽癌(R/M-NPC),并取得了明显的生存获益和良好的安全性。然而,联合疗法是否优于单用 CT 仍不清楚。我们总结了现有的证据,比较了 ICI 联合 CT 与单用 CT 的有效性和毒性:在线数据库检索了截至2023年11月1日发表的符合条件的随机对照试验(RCT)。无进展生存期(PFS)和总生存期(OS)是主要终点。客观反应率(ORR)和不良事件(AE)是次要终点:结果:纳入了三项随机对照试验(Capture-1st、JUPITER-02 和 RATIONALE-309)。与单用CT相比,一线ICI治疗联合CT可显著改善PFS(危险比[HR],0.53;95%置信区间[CI]:0.44-0.64)、OS(HR,0.63;95%CI:0.49-0.81)和ORR(几率比[OR],1.79;95%CI:1.30-2.46)。两组患者在治疗期间发生的≥3级的AE和治疗相关死亡没有显著差异:在R/M-NPC患者中,ICI治疗联合CT可改善ORR、PFS和OS,安全性与单用CT相似。
{"title":"Immune checkpoint inhibitor combined with chemotherapy versus chemotherapy alone in the first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis of random controlled trials.","authors":"Shuangyue Wang, Xiaojie Huang, Rong Li, Ziyan Zhou, Min Kang","doi":"10.1007/s00405-024-08768-w","DOIUrl":"10.1007/s00405-024-08768-w","url":null,"abstract":"<p><strong>Purpose: </strong>Immune checkpoint inhibitor (ICI) monotherapy and chemotherapy (CT) have been used to treat recurrent or metastatic nasopharyngeal carcinoma (R/M-NPC), with demonstrated survival benefits and good safety. However, whether combination therapy is superior to CT alone remains unclear. We summarized the existing evidence comparing the effectiveness and toxicities of ICI combined with CT versus CT alone.</p><p><strong>Methods: </strong>Online databases was conducted for eligible randomized controlled trials (RCTs) published up to November 1, 2023. Progression-free survival (PFS) and overall survival (OS) were the primary endpoint. Objective response rates (ORRs) and adverse events (AEs) were the secondary endpoint.</p><p><strong>Results: </strong>Three randomized controlled trials (Capture-1st, JUPITER-02, and RATIONALE-309) were included. First-line ICI therapy combined with CT showed significant improvement in PFS (hazard ratio[HR], 0.53; 95% confidence interval[CI]: 0.44-0.64), OS (HR, 0.63;95%CI: 0.49-0.81) and ORRs (odds ratio[OR], 1.79;95%CI: 1.30-2.46), when compared with CT alone. AEs ≥ grade 3 during treatment and treatment-related deaths were not significantly different between the two groups.</p><p><strong>Conclusions: </strong>In patients with R/M-NPC, ICI therapy combined with CT showed improved ORRs, PFS, and OS, with similar safety as CT alone.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141445958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Local adjuncts to minimally invasive endoscopic interventions for benign laryngotracheal stenosis: a meta-analysis. 微创内窥镜介入治疗良性喉气管狭窄的局部辅助疗法:一项荟萃分析。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-05 DOI: 10.1007/s00405-024-08810-x
Wei Ming, Jingjing Zuo, Jibo Han, Jinhui Chen

Background: Benign laryngotracheal stenosis is widely managed with minimally invasive endoscopic interventions, such as laser incision or excision scar, and dilation. However, various endoscopic treatments are significantly associated with a high recurrence rate. Local auxiliary measures, including inhalation of steroids, injection of steroids, and local topical application of mitomycin C, have been studied in order to increase the success rate.

Purpose: To compare the efficacy of endoscopic treatments with and without local adjuncts in patients with benign laryngotracheal stenosis, and analyze their clinical outcomes, recurrence, and complications.

Methods: In the meta-analysis, databases including PubMed, EMBASE, OVID, and Web of Science were searched for papers comparing the outcomes of adjunct therapy with non-adjunct therapy in patients with laryngotracheal stenosis. The duplicate publications, reviews, comments or letters, conference abstracts, and case reports were excluded. The random effect model was used for assessing the pooled risk estimates.

Results: Eight studies (1204 cases) referring to two prospective randomized controlled studies, two prospective cohort studies, and four retrospective cohort studies were ultimately included in the meta-analysis. Three delivery modes of adjuncts were identified, including intralesion steroid injection (n = 2), inhaled steroid (n = 2), and topical application of mitomycin C (n = 4). The decreased risk estimates of recurrence rate were detected in patients receiving endoscopic treatments with steroid injection or inhaled steroid, compared with endoscopic interventions alone (P < 0.05). Additionally, patients undergoing adjunct therapies had lower risk estimates of recurrence, compared to those receiving endoscopic procedures alone (P < 0.05), based on the subgroup of prospective cohort studies, subglottis, Mayer-Cotton scale of I-II degree, and stenosis length of < 3 cm. The high heterogeneity of the pooling risk estimates perhaps was due to factors of auxiliary drug, clinical characteristics of patients, and methodology. No discernible difference in the incidence of complication was identified.

Conclusions: Local application of steroids to minimally invasive interventions appear to reduce the recurrence rate of laryngotracheal stenosis. Various adjuncts available, including steroids and mitomycin C, appear to be safe and associated with a low risk estimate of adjuncts-specific complication rate. High quality multi-center randomized controlled studies are needed, with sufficient periods for follow-up and subjective and objective outcome indicators, to properly evaluate the efficacy, safety, and cost-effectiveness of adjuvant drugs.

背景:良性喉气管狭窄广泛采用内窥镜微创介入治疗,如激光切口或切除瘢痕和扩张术。然而,各种内窥镜治疗方法都与高复发率密切相关。目的:比较良性喉气管狭窄患者接受内镜治疗时使用和不使用局部辅助措施的疗效,并分析其临床效果、复发率和并发症:在荟萃分析中,我们检索了包括PubMed、EMBASE、OVID和Web of Science在内的数据库,比较了喉气管狭窄患者接受辅助治疗与不接受辅助治疗的结果。排除了重复出版物、综述、评论或信件、会议摘要和病例报告。采用随机效应模型评估汇总风险估计值:荟萃分析最终纳入了 8 项研究(1204 例),包括 2 项前瞻性随机对照研究、2 项前瞻性队列研究和 4 项回顾性队列研究。研究确定了三种辅助用药模式,包括腔内注射类固醇(2 例)、吸入类固醇(2 例)和局部应用丝裂霉素 C(4 例)。与单纯内镜干预相比,接受内镜治疗并注射类固醇或吸入类固醇的患者复发率的风险估计值有所降低(P 结论:内镜微创手术局部应用类固醇的风险估计值较低:在微创介入治疗中局部应用类固醇似乎能降低喉气管狭窄的复发率。包括类固醇和丝裂霉素 C 在内的各种辅助药物似乎都很安全,而且辅助药物特有的并发症发生率估计风险较低。为了正确评估辅助药物的疗效、安全性和成本效益,需要进行高质量的多中心随机对照研究,并设定足够的随访期和主客观结果指标。
{"title":"Local adjuncts to minimally invasive endoscopic interventions for benign laryngotracheal stenosis: a meta-analysis.","authors":"Wei Ming, Jingjing Zuo, Jibo Han, Jinhui Chen","doi":"10.1007/s00405-024-08810-x","DOIUrl":"10.1007/s00405-024-08810-x","url":null,"abstract":"<p><strong>Background: </strong>Benign laryngotracheal stenosis is widely managed with minimally invasive endoscopic interventions, such as laser incision or excision scar, and dilation. However, various endoscopic treatments are significantly associated with a high recurrence rate. Local auxiliary measures, including inhalation of steroids, injection of steroids, and local topical application of mitomycin C, have been studied in order to increase the success rate.</p><p><strong>Purpose: </strong>To compare the efficacy of endoscopic treatments with and without local adjuncts in patients with benign laryngotracheal stenosis, and analyze their clinical outcomes, recurrence, and complications.</p><p><strong>Methods: </strong>In the meta-analysis, databases including PubMed, EMBASE, OVID, and Web of Science were searched for papers comparing the outcomes of adjunct therapy with non-adjunct therapy in patients with laryngotracheal stenosis. The duplicate publications, reviews, comments or letters, conference abstracts, and case reports were excluded. The random effect model was used for assessing the pooled risk estimates.</p><p><strong>Results: </strong>Eight studies (1204 cases) referring to two prospective randomized controlled studies, two prospective cohort studies, and four retrospective cohort studies were ultimately included in the meta-analysis. Three delivery modes of adjuncts were identified, including intralesion steroid injection (n = 2), inhaled steroid (n = 2), and topical application of mitomycin C (n = 4). The decreased risk estimates of recurrence rate were detected in patients receiving endoscopic treatments with steroid injection or inhaled steroid, compared with endoscopic interventions alone (P < 0.05). Additionally, patients undergoing adjunct therapies had lower risk estimates of recurrence, compared to those receiving endoscopic procedures alone (P < 0.05), based on the subgroup of prospective cohort studies, subglottis, Mayer-Cotton scale of I-II degree, and stenosis length of < 3 cm. The high heterogeneity of the pooling risk estimates perhaps was due to factors of auxiliary drug, clinical characteristics of patients, and methodology. No discernible difference in the incidence of complication was identified.</p><p><strong>Conclusions: </strong>Local application of steroids to minimally invasive interventions appear to reduce the recurrence rate of laryngotracheal stenosis. Various adjuncts available, including steroids and mitomycin C, appear to be safe and associated with a low risk estimate of adjuncts-specific complication rate. High quality multi-center randomized controlled studies are needed, with sufficient periods for follow-up and subjective and objective outcome indicators, to properly evaluate the efficacy, safety, and cost-effectiveness of adjuvant drugs.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141534060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perichondritis of the auricle: bacterial or fungal? (A case series). 耳廓周软骨炎:细菌还是真菌? (病例系列)。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-08 DOI: 10.1007/s00405-024-08792-w
Ming Hu, Yan Cheng

Background: Suppurative perichondritis of the auricle is a common disease that can easily cause malformations if it develops into an uncontrolled infection. In nearly half of the cases, otolaryngologists cannot identify the pathogens involved.

Case presentation: In the present work, we described two cases of pyogenic perichondritis, with negative on conventional culture. However, using metagenomic next-generation sequencing (mNGS), we detected fungal infections in the patients and after the patients were given anti-fungal treatment, the patients achieved a good prognosis.

Conclusions: These cases highlighted the possibility that fungi might be the involved pathogens in patients who have had multiple negative bacterial cultures, and mNGS should be applied in these cases. mNGS could be used as a supplement to traditional culture methods.

背景:耳廓化脓性软骨周围炎是一种常见疾病,如果发展成无法控制的感染,很容易导致畸形。在近一半的病例中,耳鼻喉科医生无法确定病原体:在本研究中,我们描述了两例化脓性耳软骨炎病例,常规培养结果均为阴性。然而,通过元基因组下一代测序(mNGS),我们检测到了患者的真菌感染,在给予患者抗真菌治疗后,患者获得了良好的预后:这些病例突出表明,在细菌培养多次阴性的患者中,真菌可能是相关病原体,因此应在这些病例中应用 mNGS。
{"title":"Perichondritis of the auricle: bacterial or fungal? (A case series).","authors":"Ming Hu, Yan Cheng","doi":"10.1007/s00405-024-08792-w","DOIUrl":"10.1007/s00405-024-08792-w","url":null,"abstract":"<p><strong>Background: </strong>Suppurative perichondritis of the auricle is a common disease that can easily cause malformations if it develops into an uncontrolled infection. In nearly half of the cases, otolaryngologists cannot identify the pathogens involved.</p><p><strong>Case presentation: </strong>In the present work, we described two cases of pyogenic perichondritis, with negative on conventional culture. However, using metagenomic next-generation sequencing (mNGS), we detected fungal infections in the patients and after the patients were given anti-fungal treatment, the patients achieved a good prognosis.</p><p><strong>Conclusions: </strong>These cases highlighted the possibility that fungi might be the involved pathogens in patients who have had multiple negative bacterial cultures, and mNGS should be applied in these cases. mNGS could be used as a supplement to traditional culture methods.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11416377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141558448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of cochlear implantation on tinnitus in patients with post lingual bilateral profound hearing loss. 人工耳蜗植入对舌后双侧极重度听力损失患者耳鸣的影响。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-06-24 DOI: 10.1007/s00405-024-08764-0
Mahtab Rabbani Anari, Masoud Motasaddi Zarandy, Ali Kouhi, Saman Rezaeian, Sedighe Vaziribozorg, Mohammad Mandegari

Introduction: In this study we investigated the effect of cochlear implantation on tinnitus in patients with post lingual bilateral profound hearing loss.

Methods: In this retrospective study, 66 post-lingual deaf patients over 18 years old who referred for cochlear implantation and complained of tinnitus were included. Patients were divided into two groups with residual hearing (in frequency 250-500 Hz) and without residual hearing. All data including age, gender, type of implants, type of surgery, cause of the disease, and information on the THI score before cochlear implantation, one month after cochlear implantation and one year after cochlear implantation was recorded and analyzed.

Results: Nine patients had residual hearing, while 57 patients did not. After one month and one year, in both groups, the mean THI score has decreased significantly (p-value = 0.001), but there was no significant difference in the mean THI score before surgery and one month and one year after surgery between two groups with and without residual hearing. There was no significant difference in tinnitus severity according to THI-grade between two groups. Also there was no significant difference in THI score and the cause of the hearing loss, type and insertion method of implantation, one month and one year after the surgery between two groups.

Conclusion: According to our results, the was no significant correlation between residual hearing and tinnitus score before surgery, one month and one year after the surgery.

简介在这项研究中,我们调查了人工耳蜗植入对舌后双侧极重度听力损失患者耳鸣的影响:在这项回顾性研究中,共纳入了 66 名 18 岁以上、主诉耳鸣并转诊接受人工耳蜗植入术的舌后耳聋患者。患者被分为有残余听力(频率为 250-500 Hz)和无残余听力两组。所有数据包括年龄、性别、植入类型、手术类型、病因,以及人工耳蜗植入前、人工耳蜗植入后一个月和人工耳蜗植入后一年的 THI 评分信息,均被记录和分析:结果:9 名患者有残余听力,57 名患者没有残余听力。一个月和一年后,两组患者的平均 THI 评分均显著下降(P 值 = 0.001),但有残余听力和无残余听力两组患者术前、术后一个月和一年后的平均 THI 评分无显著差异。两组患者的耳鸣严重程度在 THI 等级上没有明显差异。此外,术后一个月和一年,两组之间的 THI 评分、听力损失原因、植入类型和植入方法也无明显差异:根据我们的研究结果,术前、术后一个月和一年,残余听力和耳鸣评分之间没有明显的相关性。
{"title":"The effect of cochlear implantation on tinnitus in patients with post lingual bilateral profound hearing loss.","authors":"Mahtab Rabbani Anari, Masoud Motasaddi Zarandy, Ali Kouhi, Saman Rezaeian, Sedighe Vaziribozorg, Mohammad Mandegari","doi":"10.1007/s00405-024-08764-0","DOIUrl":"10.1007/s00405-024-08764-0","url":null,"abstract":"<p><strong>Introduction: </strong>In this study we investigated the effect of cochlear implantation on tinnitus in patients with post lingual bilateral profound hearing loss.</p><p><strong>Methods: </strong>In this retrospective study, 66 post-lingual deaf patients over 18 years old who referred for cochlear implantation and complained of tinnitus were included. Patients were divided into two groups with residual hearing (in frequency 250-500 Hz) and without residual hearing. All data including age, gender, type of implants, type of surgery, cause of the disease, and information on the THI score before cochlear implantation, one month after cochlear implantation and one year after cochlear implantation was recorded and analyzed.</p><p><strong>Results: </strong>Nine patients had residual hearing, while 57 patients did not. After one month and one year, in both groups, the mean THI score has decreased significantly (p-value = 0.001), but there was no significant difference in the mean THI score before surgery and one month and one year after surgery between two groups with and without residual hearing. There was no significant difference in tinnitus severity according to THI-grade between two groups. Also there was no significant difference in THI score and the cause of the hearing loss, type and insertion method of implantation, one month and one year after the surgery between two groups.</p><p><strong>Conclusion: </strong>According to our results, the was no significant correlation between residual hearing and tinnitus score before surgery, one month and one year after the surgery.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141445967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endolymphatic duct blockage surgery vs. intratympanic steroids for treatment of refractory Ménière's disease. 内淋巴管阻塞手术与鼓室内类固醇治疗难治性梅尼埃病的对比。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-24 DOI: 10.1007/s00405-024-08736-4
Issam Saliba, Catherine Dufour-Fournier, Marc-Henri Asmar

Purpose: To compare the effectiveness of the Endolymphatic duct blockage (EDB) and intratympanic methylprednisolone(ITMP) injection to control refractory Ménière's disease(MD) symptoms and evaluate their impact on hearing level.

Study design: Retrospective study in a tertiary care center.

Methods: 36 received ITMP injection and 52 EDB. Mean outcome measures at 24 months included vertigo control, tinnitus, aural fullness and hearing level: pure-tone average (PTA), bone conduction average(BCA) and speech discrimination score(SDS).

Results: At 24 months postoperatively, 90.4% of the EDB group had complete control of vertigo and 43.4% of the ITMP group (p = 0.001). There was no significant difference in tinnitus or aural fullness control (p = 0.34 and p 0.21 respectively). In each group, the drop in tinnitus and aural fullness frequency at 24 months were significant for EDB (p = 0.03; p < 0.001 respectively) and for ITMP group in tinnitus (p = 0.03) but not aural fullness (p = 0.063). At 24 months, PTA, BCA and SDS were significantly worst in the ITMP group when compared to preoperative levels (p = 0.038, p = 0.027, p = 0.016). PTA in the EDB group was stable with no difference compared to ITMP group (p = 0.48). BCA and SDS in the EDB group were stable and better than the ITMP group (p = 0.032; p = 0.036). In each group, vestibular paresis was not significantly different before (p = 0.06) and after treatment (p = 0.68).

Conclusion: EDB is more effective than the ITMP for controlling the vertigo symptoms of Ménière's disease and in preserving hearing function. It is a novel surgical technique with promising results for a complete treatment of Ménière's disease. ITMP decreases the frequency and the severity of the symptoms but only control vertigo in 27.8% of cases.

目的:比较内淋巴管阻塞(EDB)和鼓膜内注射甲基强的松龙(ITMP)控制难治性梅尼埃病(MD)症状的效果,并评估它们对听力水平的影响:方法:36例接受ITMP注射,52例接受EDB。24个月的平均结果指标包括眩晕控制、耳鸣、听力饱满度和听力水平:纯音平均值(PTA)、骨导平均值(BCA)和言语辨别力评分(SDS):术后24个月,90.4%的EDB组患者眩晕症状得到完全控制,43.4%的ITMP组患者眩晕症状得到完全控制(P = 0.001)。耳鸣或听力饱满度控制方面没有明显差异(分别为 p = 0.34 和 p 0.21)。在每组中,EDB 在 24 个月时耳鸣和耳部饱胀频率的下降都很明显(p = 0.03;p 结论:EDB 比 ITMP 更有效:在控制梅尼埃病眩晕症状和保护听力功能方面,EDB 比 ITMP 更有效。这是一种新颖的外科技术,对彻底治疗梅尼埃病具有良好的效果。ITMP可降低症状的频率和严重程度,但只能控制27.8%病例的眩晕。
{"title":"Endolymphatic duct blockage surgery vs. intratympanic steroids for treatment of refractory Ménière's disease.","authors":"Issam Saliba, Catherine Dufour-Fournier, Marc-Henri Asmar","doi":"10.1007/s00405-024-08736-4","DOIUrl":"10.1007/s00405-024-08736-4","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the effectiveness of the Endolymphatic duct blockage (EDB) and intratympanic methylprednisolone(ITMP) injection to control refractory Ménière's disease(MD) symptoms and evaluate their impact on hearing level.</p><p><strong>Study design: </strong>Retrospective study in a tertiary care center.</p><p><strong>Methods: </strong>36 received ITMP injection and 52 EDB. Mean outcome measures at 24 months included vertigo control, tinnitus, aural fullness and hearing level: pure-tone average (PTA), bone conduction average(BCA) and speech discrimination score(SDS).</p><p><strong>Results: </strong>At 24 months postoperatively, 90.4% of the EDB group had complete control of vertigo and 43.4% of the ITMP group (p = 0.001). There was no significant difference in tinnitus or aural fullness control (p = 0.34 and p 0.21 respectively). In each group, the drop in tinnitus and aural fullness frequency at 24 months were significant for EDB (p = 0.03; p < 0.001 respectively) and for ITMP group in tinnitus (p = 0.03) but not aural fullness (p = 0.063). At 24 months, PTA, BCA and SDS were significantly worst in the ITMP group when compared to preoperative levels (p = 0.038, p = 0.027, p = 0.016). PTA in the EDB group was stable with no difference compared to ITMP group (p = 0.48). BCA and SDS in the EDB group were stable and better than the ITMP group (p = 0.032; p = 0.036). In each group, vestibular paresis was not significantly different before (p = 0.06) and after treatment (p = 0.68).</p><p><strong>Conclusion: </strong>EDB is more effective than the ITMP for controlling the vertigo symptoms of Ménière's disease and in preserving hearing function. It is a novel surgical technique with promising results for a complete treatment of Ménière's disease. ITMP decreases the frequency and the severity of the symptoms but only control vertigo in 27.8% of cases.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141093173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical validation of the accuracy of an intra-operative assessment tool using 3D ultrasound compared to histopathology in patients with squamous cell carcinoma of the tongue. 舌鳞状细胞癌患者术中使用三维超声评估工具的准确性与组织病理学的临床验证比较。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-06-03 DOI: 10.1007/s00405-024-08753-3
N M Bekedam, E L Koot, E M V de Cuba, M J A van Alphen, R L P van Veen, L H E Karssemakers, L E Smeele, M B Karakullukcu

Background: Histopathological analysis often shows close resection margins after surgical removal of tongue squamous cell carcinoma (TSCC). This study aimed to investigate the agreement between intraoperative 3D ultrasound (US) margin assessment and postoperative histopathology of resected TSCC.

Methods: In this study, ten patients were prospectively included. Three fiducial cannulas were inserted into the specimen. To acquire a motorized 3D US volume, the resected specimen was submerged in saline, after which images were acquired while the probe moved over the specimen. The US volumes were annotated twice: (1) automatically and (2) manually, with the automatic segmentation as initialization. After standardized histopathological processing, all hematoxylin-eosin whole slide images (WSI) were included for analysis. Corresponding US images were found based on the known WSI spacing and fiducials. Blinded observers measured the tumor thickness and the margin in the caudal, deep, and cranial directions on every slide. The anterior and posterior margin was measured per specimen.

Results: The mean difference in all measurements between manually segmented US and histopathology was 2.34 (SD: ±3.34) mm, and Spearman's rank correlation coefficient was 0.733 (p < 0.001). The smallest mean difference was in the tumor thickness with 0.80 (SD: ±2.44) mm and a correlation of 0.836 (p < 0.001). Limitations were observed in the caudal region, where no correlation was found.

Conclusion: This study shows that 3D US and histopathology have a moderate to strong statistically significant correlation (r = 0.733; p < 0.001) and a mean difference between the modalities of 2.3 mm (95%CI: -4.2; 8.9). Future research should focus on patient outcomes regarding resection margins.

背景:组织病理学分析显示,舌鳞状细胞癌(TSCC)手术切除后的切除边缘通常很近。本研究旨在探讨术中三维超声(US)边缘评估与切除的 TSCC 术后组织病理学之间的一致性:方法:本研究前瞻性地纳入了 10 例患者。在标本中插入三个靶标插管。为了获取电动三维 US 体积,切除的标本浸没在生理盐水中,然后在探针在标本上移动的同时获取图像。对 US 图像进行两次标注:(1) 自动标注;(2) 手动标注,并将自动分割作为初始化。经过标准化组织病理学处理后,所有苏木精-伊红全玻片图像(WSI)都被纳入分析范围。根据已知的 WSI 间距和靶标找到相应的 US 图像。双盲观察员测量每张切片上肿瘤的厚度以及尾部、深部和头颅方向的边缘。每个标本的前后边缘都进行了测量:结果:手动分割的 US 和组织病理学所有测量值的平均值相差 2.34(SD:±3.34)毫米,斯皮尔曼等级相关系数为 0.733(P 结论:三维 US 和组织病理学测量值的平均值相差 2.34(SD:±3.34)毫米,斯皮尔曼等级相关系数为 0.733:这项研究表明,三维 US 和组织病理学在统计学上具有中度到高度的相关性(r = 0.733; p
{"title":"Clinical validation of the accuracy of an intra-operative assessment tool using 3D ultrasound compared to histopathology in patients with squamous cell carcinoma of the tongue.","authors":"N M Bekedam, E L Koot, E M V de Cuba, M J A van Alphen, R L P van Veen, L H E Karssemakers, L E Smeele, M B Karakullukcu","doi":"10.1007/s00405-024-08753-3","DOIUrl":"10.1007/s00405-024-08753-3","url":null,"abstract":"<p><strong>Background: </strong>Histopathological analysis often shows close resection margins after surgical removal of tongue squamous cell carcinoma (TSCC). This study aimed to investigate the agreement between intraoperative 3D ultrasound (US) margin assessment and postoperative histopathology of resected TSCC.</p><p><strong>Methods: </strong>In this study, ten patients were prospectively included. Three fiducial cannulas were inserted into the specimen. To acquire a motorized 3D US volume, the resected specimen was submerged in saline, after which images were acquired while the probe moved over the specimen. The US volumes were annotated twice: (1) automatically and (2) manually, with the automatic segmentation as initialization. After standardized histopathological processing, all hematoxylin-eosin whole slide images (WSI) were included for analysis. Corresponding US images were found based on the known WSI spacing and fiducials. Blinded observers measured the tumor thickness and the margin in the caudal, deep, and cranial directions on every slide. The anterior and posterior margin was measured per specimen.</p><p><strong>Results: </strong>The mean difference in all measurements between manually segmented US and histopathology was 2.34 (SD: ±3.34) mm, and Spearman's rank correlation coefficient was 0.733 (p < 0.001). The smallest mean difference was in the tumor thickness with 0.80 (SD: ±2.44) mm and a correlation of 0.836 (p < 0.001). Limitations were observed in the caudal region, where no correlation was found.</p><p><strong>Conclusion: </strong>This study shows that 3D US and histopathology have a moderate to strong statistically significant correlation (r = 0.733; p < 0.001) and a mean difference between the modalities of 2.3 mm (95%CI: -4.2; 8.9). Future research should focus on patient outcomes regarding resection margins.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11416359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of cryotherapy on chronic rhinitis: a systematic review and meta-analysis. 冷冻疗法对慢性鼻炎的安全性和疗效:系统回顾和荟萃分析。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-10-01 Epub Date: 2024-06-06 DOI: 10.1007/s00405-024-08754-2
Farhan Alanazi, Mazyad Alenezi, Alwaleed Altimyat, Sultan Alanazy

Background: Chronic rhinitis is when the nasal passages become inflamed and irritated, causing symptoms like nasal congestion, runny nose, sneezing, and postnasal drip that last for at least 12 weeks. While various medical treatments are available for chronic rhinitis, studies have shown that patients often do not comply with the treatment or report that it is ineffective. Cryotherapy for the nasal mucosa is a surgical option that has shown promise for these patients, with acceptable side effects.

Aim: Our goal is to evaluate the existing literature regarding the effectiveness and safety of cryotherapy as a treatment for chronic rhinitis.

Methods: We searched four electronic databases for relevant studies. Data were extracted from the included studies after screening procedures. Using the random effect model, we calculated the pooled mean difference (MD) for our continuous outcomes and pooled proportions for categorical outcomes. The I2 test was used to detect heterogenicity. Randomized controlled trials (RCTs) were assessed for methodological quality using the Cochrane risk of bias assessment tool 2, while observational studies and single-arm studies were assessed using the National Institutes of Health's tools.

Results: Our study comprised 21 studies; eighteen were eligible for analysis, with 1663 patients with chronic rhinitis. All of our assessed outcomes showed improvement with cryotherapy from their baseline status. Our pooled MDs for Total Nasal Symptom Score (rTNSS), Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), and Nasal Obstruction Symptom Evaluation (NOSE) scores were as follows: ( - 3.58, 95% CI [ - 3.80,  - 3.37], p < 0.001), ( - 1.48, 95% CI [ - 1.68,  - 1.27], p < 0.001), and ( - 26.65, 95% CI [ - 33.98,  - 19.31], p < 0.001), respectively. Regarding nasal obstruction and rhinorrhea, cryotherapy showed effectiveness in 61% and 52% of patients in the complete relief subgroup and 26% and 34% in the < 50%-relief subgroup, respectively.

Conclusion: We observed significant improvement in our measured outcomes as rTNSS, RQLQ, and NOSE scores compared to the baseline state, demonstrating the cryotherapy's efficacy. This improvement was consistent in all subsequent follow-up periods. However, we need more high-quality RCTs for stronger evidence to be generalized.

背景:慢性鼻炎是指鼻腔发炎和受刺激,导致鼻塞、流鼻涕、打喷嚏和鼻后滴流等症状,并持续至少 12 周。虽然慢性鼻炎有多种药物治疗方法,但研究表明,患者往往不配合治疗或表示治疗无效。鼻粘膜冷冻疗法是一种手术治疗方法,对这些患者的治疗前景看好,而且副作用可以接受。目的:我们的目标是评估现有文献中有关冷冻疗法作为慢性鼻炎治疗方法的有效性和安全性:我们在四个电子数据库中搜索了相关研究。方法:我们在四个电子数据库中搜索了相关研究,经过筛选后从纳入的研究中提取了数据。使用随机效应模型,我们计算了连续结果的集合平均差(MD)和分类结果的集合比例。I2 检验用于检测异质性。随机对照试验(RCT)采用 Cochrane 偏倚风险评估工具 2 进行方法学质量评估,观察性研究和单臂研究则采用美国国立卫生研究院的工具进行评估:我们的研究包括 21 项研究,其中 18 项符合分析条件,共涉及 1663 名慢性鼻炎患者。我们评估的所有结果均显示,冷冻疗法可改善患者的基线状况。我们对鼻部症状总评分(rTNSS)、鼻结膜炎生活质量问卷(RQLQ)和鼻阻塞症状评估(NOSE)评分的汇总MD值如下:( - 3.58,95% CI [ - 3.80,- 3.37],P 结论:与基线状态相比,我们观察到 rTNSS、RQLQ 和 NOSE 评分等测量结果均有明显改善,这证明了冷冻疗法的疗效。这种改善在随后的所有随访期间都是一致的。不过,我们还需要更多高质量的 RCT,以获得更有力的证据来推广。
{"title":"Safety and efficacy of cryotherapy on chronic rhinitis: a systematic review and meta-analysis.","authors":"Farhan Alanazi, Mazyad Alenezi, Alwaleed Altimyat, Sultan Alanazy","doi":"10.1007/s00405-024-08754-2","DOIUrl":"10.1007/s00405-024-08754-2","url":null,"abstract":"<p><strong>Background: </strong>Chronic rhinitis is when the nasal passages become inflamed and irritated, causing symptoms like nasal congestion, runny nose, sneezing, and postnasal drip that last for at least 12 weeks. While various medical treatments are available for chronic rhinitis, studies have shown that patients often do not comply with the treatment or report that it is ineffective. Cryotherapy for the nasal mucosa is a surgical option that has shown promise for these patients, with acceptable side effects.</p><p><strong>Aim: </strong>Our goal is to evaluate the existing literature regarding the effectiveness and safety of cryotherapy as a treatment for chronic rhinitis.</p><p><strong>Methods: </strong>We searched four electronic databases for relevant studies. Data were extracted from the included studies after screening procedures. Using the random effect model, we calculated the pooled mean difference (MD) for our continuous outcomes and pooled proportions for categorical outcomes. The I<sup>2</sup> test was used to detect heterogenicity. Randomized controlled trials (RCTs) were assessed for methodological quality using the Cochrane risk of bias assessment tool 2, while observational studies and single-arm studies were assessed using the National Institutes of Health's tools.</p><p><strong>Results: </strong>Our study comprised 21 studies; eighteen were eligible for analysis, with 1663 patients with chronic rhinitis. All of our assessed outcomes showed improvement with cryotherapy from their baseline status. Our pooled MDs for Total Nasal Symptom Score (rTNSS), Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), and Nasal Obstruction Symptom Evaluation (NOSE) scores were as follows: ( - 3.58, 95% CI [ - 3.80,  - 3.37], p < 0.001), ( - 1.48, 95% CI [ - 1.68,  - 1.27], p < 0.001), and ( - 26.65, 95% CI [ - 33.98,  - 19.31], p < 0.001), respectively. Regarding nasal obstruction and rhinorrhea, cryotherapy showed effectiveness in 61% and 52% of patients in the complete relief subgroup and 26% and 34% in the < 50%-relief subgroup, respectively.</p><p><strong>Conclusion: </strong>We observed significant improvement in our measured outcomes as rTNSS, RQLQ, and NOSE scores compared to the baseline state, demonstrating the cryotherapy's efficacy. This improvement was consistent in all subsequent follow-up periods. However, we need more high-quality RCTs for stronger evidence to be generalized.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141283299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of cricoarytenoid joint ankylosis in bilateral vocal cord immobility. 环杓关节强直在双侧声带活动障碍中的作用。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-09-24 DOI: 10.1007/s00405-024-08988-0
Wan-Fu Su, Chi-Jen Chen, Yun-Chen Huang, Ying-Chieh Hsu, Po-Yun Ko, Shao-Cheng Liu

Objectives: To stratify the severity of cricoarytenoid joint fixation (CAJF) by surgery and understand the role of it played in the bilateral vocal fold immobility (BVFI). The second objective emphasizes on the significance of the preoperative differential diagnosis from neurogenic immobility with medical history and endoscopic findings.

Methods: A retrospective review was conducted of 74 patients between 2005 and 2022. Careful medical history inquiry, and videolaryngoscopy are conducted to recruit the appropriate surgical candidates. All patients underwent arytenoid remobilization (AR) followed by vocal fold medialization with arytenoid adduction (AA) or lateralization with suture lateralization (SL). The severity of CAJF is graded during the operation or inferred based on the period from operation to recurrence.

Result: A total of 18 patients, aged between 18 and 76 years, were analyzed. Among them, 14 cases were classified as the adducted type with ventilation problems, with three presenting with dyspnea, and 11 requiring artificial airways. Additionally, four patients presented with the abducted type, characterized by aphonia. Meanwhile, two additional cases were considered for comparison but were not included in this cohort of 18 subjects due to incorrect diagnosis and inappropriate management. Using AR procedure, the AA procedure offered three aphonia subjects a voiced sound without airway impairment and the SL procedure decannulated 100% (11/11) of the artificial airways and improved the airway patency in 100% (3/3) of the non-tracheostomized subjects despite the severity of CAJF. The severity of joint ankylosis was distributed as follows: In the aphonia group, there were three subjects with grade I, one subject with grade II, and 0 subjects with grade III. In the ventilation group, there was one subject with grade I, seven subjects with grade II, and six subjects with grade III. In contrast, the two cases used for comparison experienced recurrent dyspnea and failed decannulation because the AR procedure was not performed. The follow-up period was averaged in 58 and 14 months at least.

Conclusion: From this experience, it is the accurate preoperative diagnosis instead of the severity of CAJF that determines the successful rate in airway patency and voiced phonation if the AR procedure is utilized. Careful medical history inquiry and videolaryngoscopic examination can correctly differentiate the mechanical from neurogenic origin without the help of EMG. Evidence of level: 4.

目的通过手术对环状腱膜关节固定术(CAJF)的严重程度进行分层,并了解其在双侧声带固定术(BVFI)中的作用。第二个目的是强调术前根据病史和内窥镜检查结果与神经源性声带不动进行鉴别诊断的重要性:方法:对 2005 年至 2022 年间的 74 例患者进行了回顾性研究。方法:对 2005 年至 2022 年间的 74 例患者进行回顾性研究,仔细询问病史并进行视频喉镜检查,以确定合适的手术人选。所有患者均接受了杓状肌再固定术(AR),随后进行了声带内侧化,杓状肌内收(AA)或缝合侧化(SL)。CAJF 的严重程度在手术过程中分级,或根据从手术到复发的时间推断:结果:共分析了 18 名患者,年龄在 18 岁至 76 岁之间。其中,14 例被归类为有通气问题的内收型,3 例出现呼吸困难,11 例需要人工气道。此外,4 名患者属于内收型,表现为失语。同时,还有两个病例被考虑用于比较,但由于诊断不正确和处理不当,这两个病例未被纳入本组的 18 名受试者中。使用 AR 程序,AA 程序为三名失声受试者提供了发声功能,且未造成气道损伤;SL 程序使 100%(11/11)的人工气道解禁,并改善了 100%(3/3)非气管造口受试者的气道通畅性,尽管 CAJF 的严重程度不同。关节强直的严重程度分布如下:在失声组中,3 名受试者为 I 级,1 名受试者为 II 级,0 名受试者为 III 级。通气组中,I 级 1 例,II 级 7 例,III 级 6 例。相比之下,用于对比的两个病例出现了反复呼吸困难,并因未进行 AR 程序而导致解禁失败。平均随访时间分别为 58 个月和至少 14 个月:结论:从本次经验来看,准确的术前诊断而非 CAJF 的严重程度决定了使用 AR 手术的气道通畅和语音发音的成功率。仔细询问病史和进行视频喉镜检查可以正确区分机械性和神经源性,而无需借助肌电图。证据等级:4。
{"title":"The role of cricoarytenoid joint ankylosis in bilateral vocal cord immobility.","authors":"Wan-Fu Su, Chi-Jen Chen, Yun-Chen Huang, Ying-Chieh Hsu, Po-Yun Ko, Shao-Cheng Liu","doi":"10.1007/s00405-024-08988-0","DOIUrl":"https://doi.org/10.1007/s00405-024-08988-0","url":null,"abstract":"<p><strong>Objectives: </strong>To stratify the severity of cricoarytenoid joint fixation (CAJF) by surgery and understand the role of it played in the bilateral vocal fold immobility (BVFI). The second objective emphasizes on the significance of the preoperative differential diagnosis from neurogenic immobility with medical history and endoscopic findings.</p><p><strong>Methods: </strong>A retrospective review was conducted of 74 patients between 2005 and 2022. Careful medical history inquiry, and videolaryngoscopy are conducted to recruit the appropriate surgical candidates. All patients underwent arytenoid remobilization (AR) followed by vocal fold medialization with arytenoid adduction (AA) or lateralization with suture lateralization (SL). The severity of CAJF is graded during the operation or inferred based on the period from operation to recurrence.</p><p><strong>Result: </strong>A total of 18 patients, aged between 18 and 76 years, were analyzed. Among them, 14 cases were classified as the adducted type with ventilation problems, with three presenting with dyspnea, and 11 requiring artificial airways. Additionally, four patients presented with the abducted type, characterized by aphonia. Meanwhile, two additional cases were considered for comparison but were not included in this cohort of 18 subjects due to incorrect diagnosis and inappropriate management. Using AR procedure, the AA procedure offered three aphonia subjects a voiced sound without airway impairment and the SL procedure decannulated 100% (11/11) of the artificial airways and improved the airway patency in 100% (3/3) of the non-tracheostomized subjects despite the severity of CAJF. The severity of joint ankylosis was distributed as follows: In the aphonia group, there were three subjects with grade I, one subject with grade II, and 0 subjects with grade III. In the ventilation group, there was one subject with grade I, seven subjects with grade II, and six subjects with grade III. In contrast, the two cases used for comparison experienced recurrent dyspnea and failed decannulation because the AR procedure was not performed. The follow-up period was averaged in 58 and 14 months at least.</p><p><strong>Conclusion: </strong>From this experience, it is the accurate preoperative diagnosis instead of the severity of CAJF that determines the successful rate in airway patency and voiced phonation if the AR procedure is utilized. Careful medical history inquiry and videolaryngoscopic examination can correctly differentiate the mechanical from neurogenic origin without the help of EMG. Evidence of level: 4.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142307360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticoagulation for cavernous sinus thrombosis: a systematic review and individual patient data meta-analysis. 海绵窦血栓形成的抗凝治疗:系统回顾和个体患者数据荟萃分析。
IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-09-23 DOI: 10.1007/s00405-024-08992-4
Chatdanai Akarapas, Nutchar Wiwatkunupakarn, Suchanya Sithirungson, Saisawat Chaiyasate

Purpose: Septic cavernous sinus thrombosis (SCST) is a rare but life-threatening condition with high mortality and morbidity. The role of anticoagulation in the treatment of SCST remains unclear because there is limited evidence to support this treatment. This study aims to explore (1) the association between anticoagulation administration and mortality of cavernous sinus thrombosis from sinusitis, and (2) the types and duration of anticoagulation used.

Methods: This review was undertaken and reported in accordance with PRISMA guidelines. We included the studies that reported individual data of adult patients (≥ 18 years) diagnosed with cavernous sinus thrombosis from sinusitis confirmed by objective methods with documented therapy and outcome. A systematic search carried out in Embase, Medline, Scopus, and CENTRAL by two reviewers up to Dec 2023. The quality was evaluated using tool proposed by Murad et al. The logistic regression analysis was employed to adjust the confounding factors.

Results: A total of 72 articles with 110 patients, were eligible for inclusion in our meta-analysis. There was a significant difference less mortality in the group that received anticoagulants (3.3 vs. 18%, p = 0.022). The adjusted odds ratio for mortality in the anticoagulant-given group is 0.067 (0.009, 0.475). Heparin is the most frequently used initial agent and one-third of patients receiving anticoagulants for three months.

Conclusion: In an adult patient diagnosed with cavernous sinus thrombosis, there was a strong suggestion that anticoagulation could improve mortality. We recommend that patients with hyperglycemia should be carefully considered before receiving an anticoagulant.

目的:化脓性海绵窦血栓形成(SCST)是一种罕见的危及生命的疾病,死亡率和发病率都很高。由于支持抗凝治疗的证据有限,因此抗凝治疗在 SCST 治疗中的作用仍不明确。本研究旨在探讨:(1) 抗凝治疗与鼻窦炎导致的海绵窦血栓死亡率之间的关系;(2) 抗凝治疗的类型和持续时间:本综述按照 PRISMA 指南进行研究和报告。我们纳入了报告经客观方法确诊为鼻窦炎引起的海绵窦血栓的成年患者(≥ 18 岁)的个人数据,并记录了治疗方法和结果的研究。截至 2023 年 12 月,由两名审稿人在 Embase、Medline、Scopus 和 CENTRAL 中进行了系统检索。采用逻辑回归分析法调整混杂因素:共有 72 篇文章、110 名患者符合纳入荟萃分析的条件。接受抗凝药物治疗组的死亡率明显低于接受抗凝药物治疗组(3.3% 对 18%,P = 0.022)。给予抗凝剂组的死亡率调整后的几率比为 0.067 (0.009, 0.475)。肝素是最常用的初始药物,三分之一的患者接受抗凝剂治疗三个月:在确诊为海绵窦血栓形成的成人患者中,抗凝治疗可提高死亡率。我们建议,高血糖患者在接受抗凝治疗前应慎重考虑。
{"title":"Anticoagulation for cavernous sinus thrombosis: a systematic review and individual patient data meta-analysis.","authors":"Chatdanai Akarapas, Nutchar Wiwatkunupakarn, Suchanya Sithirungson, Saisawat Chaiyasate","doi":"10.1007/s00405-024-08992-4","DOIUrl":"https://doi.org/10.1007/s00405-024-08992-4","url":null,"abstract":"<p><strong>Purpose: </strong>Septic cavernous sinus thrombosis (SCST) is a rare but life-threatening condition with high mortality and morbidity. The role of anticoagulation in the treatment of SCST remains unclear because there is limited evidence to support this treatment. This study aims to explore (1) the association between anticoagulation administration and mortality of cavernous sinus thrombosis from sinusitis, and (2) the types and duration of anticoagulation used.</p><p><strong>Methods: </strong>This review was undertaken and reported in accordance with PRISMA guidelines. We included the studies that reported individual data of adult patients (≥ 18 years) diagnosed with cavernous sinus thrombosis from sinusitis confirmed by objective methods with documented therapy and outcome. A systematic search carried out in Embase, Medline, Scopus, and CENTRAL by two reviewers up to Dec 2023. The quality was evaluated using tool proposed by Murad et al. The logistic regression analysis was employed to adjust the confounding factors.</p><p><strong>Results: </strong>A total of 72 articles with 110 patients, were eligible for inclusion in our meta-analysis. There was a significant difference less mortality in the group that received anticoagulants (3.3 vs. 18%, p = 0.022). The adjusted odds ratio for mortality in the anticoagulant-given group is 0.067 (0.009, 0.475). Heparin is the most frequently used initial agent and one-third of patients receiving anticoagulants for three months.</p><p><strong>Conclusion: </strong>In an adult patient diagnosed with cavernous sinus thrombosis, there was a strong suggestion that anticoagulation could improve mortality. We recommend that patients with hyperglycemia should be carefully considered before receiving an anticoagulant.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Archives of Oto-Rhino-Laryngology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1